Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Telmisartan Long-term Follow-up in Hypertension
NCT02177422Phase 3Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 1998
- Primary completion
- Nov 1999
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of telmisartan in hypertension (HTN), sponsored by Boehringer Ingelheim. Primary endpoints: Achievement of goal blood pressure response at 1 year, Need for addition of hydrochlorothiazide or subsequent change in antihypertensive therapy at 1 year and 8 more. Started Jun 1998; status: completed.
02
Drugs
telmisartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT02177422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02177422.